APA (7th ed.) Citation

Dorweiler, T. F., Singh, A., Ganju, A., Lydic, T. A., Glazer, L. C., Kolesnick, R. N., & Busik, J. V. (2024). Diabetic retinopathy is a ceramidopathy reversible by anti-ceramide immunotherapy. Cell metabolism, 36(7), 1521-1533.e5. https://doi.org/10.1016/j.cmet.2024.04.013

Chicago Style (17th ed.) Citation

Dorweiler, Tim F., Arjun Singh, Aditya Ganju, Todd A. Lydic, Louis C. Glazer, Richard N. Kolesnick, and Julia V. Busik. "Diabetic Retinopathy Is a Ceramidopathy Reversible by Anti-ceramide Immunotherapy." Cell Metabolism 36, no. 7 (2024): 1521-1533.e5. https://doi.org/10.1016/j.cmet.2024.04.013.

MLA (9th ed.) Citation

Dorweiler, Tim F., et al. "Diabetic Retinopathy Is a Ceramidopathy Reversible by Anti-ceramide Immunotherapy." Cell Metabolism, vol. 36, no. 7, 2024, pp. 1521-1533.e5, https://doi.org/10.1016/j.cmet.2024.04.013.